Trial intelligence / Profile preview

Ticagrelor Effects on Microparticles in NSTE-ACS (TIGER-M)

NCT02071966Phase 4Terminated

Sponsor
Università Cattolica del Sacro Cuore
Start
Nov 2012
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in non-ST elevation acute coronary syndrome (NSTE-ACS), sponsored by Università Cattolica del Sacro Cuore. Started Nov 2012; status: terminated.

02

Drugs

ticagrelor
03

Conditions

non-ST elevation acute coronary syndrome (NSTE-ACS)

Beyond the preview

Go deeper on NCT02071966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02071966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call